Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -350.60% | -284.39% | -261.12% | 43.32% | 80.88% |
| Total Depreciation and Amortization | 7.99% | -7.69% | -17.71% | -87.65% | -89.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 965.83% | -893.75% | 80.84% | -96.00% | -91.01% |
| Change in Net Operating Assets | 151.09% | 926.05% | -46.04% | 1,126.31% | -278,250.00% |
| Cash from Operations | -115.91% | 1.87% | -102.08% | 82.72% | 58.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,009.50% | -- | -1,049.14% | -- | -- |
| Cash from Investing | -6,009.50% | -- | -1,184.68% | -- | -- |
| Total Debt Issued | 984.32% | -- | -- | -- | -- |
| Total Debt Repaid | -58.50% | -17.79% | 91.61% | 73.31% | 72.93% |
| Issuance of Common Stock | -84.51% | -- | -- | 15,791.38% | 3,346.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 450.99% | 9,891.67% | 12,395.44% | 4,380.05% | 118.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.65% | 427.93% | 90.85% | 155.64% | 81.61% |